Mogrosides regulate tumor metabolism and immune response, revealing dual anticancer mechanism
The monk fruit, a small green gourd native to the mountainous forests of Guangxi province in southern China, has been ...
Tag: tumor microenvironment targeting
New strategy strengthens CAR-T cells against solid tumors, potentially transforming cancer treatment
For years, CAR-T cell therapy has stood as one of cancer medicine’s most striking successes. By removing a patient’s T ...
Targeting a signaling pathway activated by acidic tumor environment restores treatment response to PARP inhibitors in ovarian cancer
PARP inhibitors are among the most widely used therapies for ovarian cancer, but their long-term effectiveness is limited by acquired resistance Researchers ...
Study Finds Casdatifan Produces Durable Tumor Responses in Advanced Kidney Cancer
A new multi-center Phase 1 study is testing casdatifan, an investigational oral therapy designed to inhibit hypoxia-inducible factor-2 alpha (HIF-2α), ...
Radiopharmaceutical Therapy Targeting FAP Demonstrates Wide-Ranging Efficacy Across Various Cancer Types
A groundbreaking advancement in cancer treatment has emerged with the development of novel radiopharmaceutical therapies targeting fibroblast activation protein (FAP), ...
UMass Amherst Scientists Harness Bacteria and Viruses to Pioneer Novel Cancer-Fighting Strategy
In a groundbreaking study that could revolutionize treatment paradigms for some of the most lethal forms of cancer, researchers at ...
New Combo Shows Promise for Unknown Primary Cancer
In a groundbreaking advancement in oncological therapeutics, researchers have unveiled promising results from a phase II clinical trial investigating a ...
How 3D Printing Is Revolutionizing the Delivery of Cancer Drugs to Tumors
Recent advancements from the University of Mississippi offer a promising breakthrough in cancer therapy through the development of 3D-printed spanlastic ...
uPAR: A Promising Target for CAR T Cell Therapy in Solid Tumors
A groundbreaking advancement in cancer immunotherapy has emerged from the laboratories of Memorial Sloan Kettering Cancer Center (MSK), where scientists ...
Durvalumab, Cediranib ± Olaparib in Recurrent Ovarian Cancer
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!